openPR Logo
Press release

Meningococcal Vaccines Market: In-Depth Analysis of Industry Growth Drivers, Restraints and Opportunities Is Done To Assist the Stakeholders to Understand the Various Factors Affecting the Market

02-01-2019 10:21 AM CET | Health & Medicine

Press release from: Allied Market Research

Meningococcal Vaccines Market

Meningococcal Vaccines Market

Meningococcal vaccine is used to treat meningitis caused by N. meningitidis bacteria. Previously, there were no prior measures to prevent meningitis. After infection was confirmed using antibiotics along with nutritional supplements, the disease was treated. However, with the advent of the meningococcal vaccine, meningitis could be prevented. The global vaccine market is estimated at $ 24 billion in 2013. The worldwide increase in meningitis is a major driver of this market. As the awareness of the disease and its vaccine grows, the meningococcal vaccine market also grows. Maintaining a cold chain for vaccination increases immunization costs and is a major limiting factor in this market. The World Health Organization is promoting a meningitis prevention strategy and hopes to introduce this vaccine in 26 countries in Africa suffering from meningitis and hopes to develop the vaccine by 2016.

Meningococcal vaccines types market analysis

The meningococcal vaccine market can be classified based on its types into quadrivalent, bivalent, serogroup A, serogroup B and serogroup X. Polysaccharide and conjugate are two types of quadrivalent vaccine. A new vaccine named Baxsero, a conjugate vaccine has been a huge success in prevention of meningitis.

Meningococcal vaccines geography market analysis

This market is classified based on its geography into North America, Europe, Asia-Pacific and rest of the world (RoW). North American market is the highest revenue generating region for this vaccine.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/330

Competitive Landscape

The major players in this market are Sanofi S.A., Novartis International, GlaxoSmithKline, Pfizer Inc., Serum Institute of India Ltd., JN-International Medical Corporation, Nuron Biotech, Baxter International and Biomed Pvt. Ltd. Novartis International with its new product is dominating the market. It has come up with a new vaccine named Baxsero, which has proved to be very beneficial in preventing meningitis. Pfizer Inc. is planning to target adolescent with their vaccine.

High level analysis

The report analyses global meningococcal vaccines market with the help of Porter’s five forces model. Porter’s model helps in analyzing the market players, new entrants in the market and the strategies adopted by them. In this market, the unavailability of substitutes result in high bargaining power of suppliers and low bargaining power of buyers. The meningococcal vaccine is a capital-intensive market; therefore, it is difficult for new entrants to enter the business. Market dynamics is analyzed for the benefit of the stakeholders.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/330

KEY BENEFITS

• Estimations are made by considering current market trends, and future potential investment for analysis period 2014-2020
• Benefits of meningococcal vaccines in prevention of meningitis are explained in the report
• In-depth analysis of market growth drivers, restraints and opportunities is done to assist the stakeholders in understanding the various factors affecting this market
• Macro environmental analysis of the market is done using Porter’s five forces model to analyze the various components of this industry.
• The market is analyzed based on its type and geography to help the stakeholders in understanding the market and its trends.

Access Full Summery @ https://www.alliedmarketresearch.com/meningococcal-vaccines-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Meningococcal Vaccines Market: In-Depth Analysis of Industry Growth Drivers, Restraints and Opportunities Is Done To Assist the Stakeholders to Understand the Various Factors Affecting the Market here

News-ID: 1552862 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Meningococcal

Impact Of Rising Healthcare Spending On Meningococcal Vaccines: An Emerging Driv …
The Meningococcal Vaccines Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Meningococcal Vaccines Market Size and Projected Growth Rate? The market size for meningococcal vaccines has seen rapid expansion in the past few years. The market is forecasted to increase from $3.89 billion
Meningococcal Vaccines Market: Combating Life-Threatening Infections
In recent years, the global Meningococcal Vaccines Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Meningococcal Vaccines Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
Meningococcal Vaccines Market
Meningococcal Vaccines Market 2022 The Meningococcal Vaccines Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire
Meningococcal Vaccines Market Report Up to 2031
Visiongain has published a new report on Meningococcal Vaccines Market Report 2021-2031: Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by End-user (Paediatric, Adult, Traveler), by Brand (Bexsero, Menactra, Menveo, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/meningococcal-vaccines-market-2021/#download_sampe_div Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations
Global Meningococcal Vaccines Market Research Report
This report studies the global Meningococcal Vaccines market status and forecast, categorizes the global Meningococcal Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline JN-International Medical Novartis International Sanofi Pfizer Baxter International Geographically, this report studies the top producers and
Meningococcal Vaccines Market Growth by 2028 | GlaxoSmithKline, Polysaccharide M …
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of